More on RAPP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $41.47 |
|
|||
| Open | $41.01 | ||||
| 52 Wk High | $3.75 | ||||
| 52 Wk Low | $0.25 | ||||
| Day High | $41.47 | ||||
| Day Low | $34.40 | ||||
| P/E | 3,467.00 | ||||
| EPS | $0.01 | ||||
| Volume | 376,632 | ||||
- Rapport Therapeutics (RAPP) Reiterated at Market Outperform by Citizens on Positive Ph2 Results
- Raymond James Reiterates Strong Buy Rating on Rapport Therapeutics (RAPP)
- Rapport Therapeutics (RAPP) Reiterated at Buy by Stifel
- Rapport Therapeutics (RAPP) PT Raised to $75 at BTIG
- Truist on Rapport Therapeutics (RAPP): 'Assessing the RAP-219 Bipolar Mania Opportunity Ahead of October PoC Data'
- Rapport Therapeutics to Participate in Upcoming Investor Conferences
- Form 4 Rapport Therapeutics, For: Aug 25 Filed by: Ceesay Abraham
- Form 4 Rapport Therapeutics, For: Aug 24 Filed by: Yeleswaram Krishnaswamy
- Form 144 Rapport Therapeutics, Filed by: Yeleswaram Krishnaswamy
- Form 144 Rapport Therapeutics, Filed by: Yeleswaram Krishnaswamy
Entities mentioned with rapp
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- Stifel | View Related Stories »
- Earnings | View Related Stories »
- Cowen & Co | View Related Stories »
- S1 | View Related Stories »
- Show More...
